Literature DB >> 3006944

Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction.

J McElveen, M I Mackness, C M Colley, T Peard, S Warner, C H Walker.   

Abstract

The activity of paraoxonase in serum was found to be bimodally distributed, both in a control group and in a group of patients who had suffered myocardial infarction. Activity in the myocardial infarct group was significantly lower than in the control group. Low paraoxonase activity in serum may provide an indication of susceptibility to the development of coronary heart disease.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3006944

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


  33 in total

1.  Serum paraoxonase activity is associated with variants in the PON gene cluster and risk of Alzheimer disease.

Authors:  Porat M Erlich; Kathryn L Lunetta; L Adrienne Cupples; Carmela R Abraham; Robert C Green; Clinton T Baldwin; Lindsay A Farrer
Journal:  Neurobiol Aging       Date:  2010-10-27       Impact factor: 4.673

2.  Relationship of PON1 192 and 55 gene polymorphisms to calcific valvular aortic stenosis.

Authors:  Luis M Moura; Susana Faria; Miguel Brito; Fausto J Pinto; Steen D Kristensen; Isabel M Barros; Nalini Rajamannan; Francisco Rocha-Gonçalves
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

3.  Distinction between 'A'-esterases and arylesterases. Implications for esterase classification.

Authors:  M I Mackness; H M Thompson; A R Hardy; C H Walker
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

Review 4.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

5.  Immunobiochemical analysis of Paraoxonase1 (anti-oxidant), xanthine oxidase (oxidant) enzymes and lipid profile of cardiac disease patients in Lahore Metropolitan, Pakistan.

Authors:  Zahoor Qadir Samra; Adeela Sana; Sadia Bano; Mariam Farooq; Nadia Dar; Muhammad Amin Athar
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 6.  The human serum paraoxonase/arylesterase polymorphism.

Authors:  B N La Du
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

7.  Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.

Authors:  Ayşe Yeşim Göçmen; Saadet Gümüşlü; Ender Semiz
Journal:  Clin Cardiol       Date:  2004-07       Impact factor: 2.882

8.  Serum paraoxonase 1 activity is decreased in thyroid dysfunction.

Authors:  F Azizi; F Raiszadeh; M Solati; A Etemadi; M Rahmani; M Arabi
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

9.  Decreased paraoxonase activity in critically ill patients with sepsis.

Authors:  Frantisek Novak; Lucie Vavrova; Jana Kodydkova; Frantisek Novak; Magdalena Hynkova; Ales Zak; Olga Novakova
Journal:  Clin Exp Med       Date:  2009-09-04       Impact factor: 3.984

10.  Paraoxonase activity in human pericardial fluid: its relationship to coronary artery disease.

Authors:  A F Hernandez; A Pla; A Valenzuela; F Gil; H P Hougen; E Villanueva
Journal:  Int J Legal Med       Date:  1993       Impact factor: 2.686
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.